Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011)
Vanda Pharmaceuticals' (VNDA) quarterly Change in Taxes came in at -$2.1 million in Q4 2011, down 417.95% year-on-year from $663000.0 in Q4 2010, and down 1765.49% quarter-over-quarter from -$113000.0 in Q3 2011.
Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011) Analysis & Trends
Vanda Pharmaceuticals has disclosed Change in Taxes across 2 years of filings, most recently posting -$2.1 million for Q4 2011.
- Change in Taxes for Q4 2011 came in at -$2.1 million, down 417.95% year-over-year; the trailing twelve-month figure through Dec 2011 was -$2.3 million (changed N/A YoY), and the FY2011 annual result was -$2.3 million, down 158.13% from the prior year.
- Change in Taxes came in at -$2.1 million for Q4 2011 at Vanda Pharmaceuticals, down from -$113000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $663000.0 in Q4 2010 to a low of -$2.5 million in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 349.92 Mn | 147.61 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -2.11 Mn |
| Dec 31, 2011 | -2.11 Mn |
| Sep 30, 2011 | -113,000.00 |
| Sep 30, 2011 | -113,000.00 |
| Jun 30, 2011 | -51,000.00 |
| Jun 30, 2011 | -51,000.00 |
| Mar 31, 2011 | 6,000.00 |
| Mar 31, 2011 | 6,000.00 |
| Dec 31, 2010 | 663,000.00 |
| Dec 31, 2010 | 663,000.00 |
| Sep 30, 2010 | -2.53 Mn |
| Sep 30, 2010 | -2.53 Mn |